#orphan
CNBC’s Becky Quick to Moderate High-Level CEO Panel at NORD’s 2026 Rare Diseases & Orphan Products Breakthrough Summit
WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has announced that Becky Quick,...
Top Federal Health Officials to Headline NORD’s 2026 Rare Diseases and Orphan Products Breakthrough Summit in Washington, D.C.
WASHINGTON, D.C. and NORWELL, Mass. — Three of the nation’s most influential federal health leaders are set to...
National Organization for Rare Disorders Mourns the Passing of Former U.S. Senator Nancy Kassebaum Baker, Champion of the Orphan Drug Act
The National Organization for Rare Disorders (NORD) has expressed its profound sorrow following the passing of former U.S....
Former U.S. Senator Nancy Kassebaum Baker Remembered for Transformative Role in Rare Disease Legislation and the Passage of the Orphan Drug Act
21 September 2026
The National Organization for Rare Disorders (NORD) has expressed its profound sorrow following the passing of former U.S. Senator Nancy...